Picture of Adalta logo

1AD — Adalta News Story

0.000.00%
au flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Australia's AdAlta surges as partner lands up to $120 million cell therapy deal

BUZZ-Australia's AdAlta surges as partner lands up to $120 million cell therapy deal

** Shares of AdAlta 1AD.AX rise as much as 33.3% to A$0.0040, marking their biggest intraday pct gain since September 3

** Shares hit their highest level since September 4

** Biotech firm says its cell therapy manufacturing partner Oribiotech has signed a 10-year agreement worth up to US$120 million

** Adds, deal will integrate Oribiotech's IRO automated manufacturing platform for cell therapies into production of an approved and commercialised cell therapy

** 1AD up 16.7% so far this week, its strongest weekly move since August 17

** Nearly 14 million shares change hands, about 7.8x the 30-day average

** YTD, stock up 16.7%, including session's moves


(Reporting by Subhalakshmi Dey in Bengaluru)

((Subhalakshmi.Dey@thomsonreuters.com;))

Recent news on Adalta

See all news